Page last updated: 2024-11-03

ono 1078 and Lupus Erythematosus, Systemic

ono 1078 has been researched along with Lupus Erythematosus, Systemic in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenwasser, LJ1

Other Studies

1 other study available for ono 1078 and Lupus Erythematosus, Systemic

ArticleYear
Leukotriene modifiers: new drugs, old and new reactions.
    The Journal of allergy and clinical immunology, 1999, Volume: 103, Issue:3 Pt 1

    Topics: Acetates; Anti-Asthmatic Agents; Asthma; Autoimmune Diseases; Chromones; Churg-Strauss Syndrome; Cyc

1999